Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 187.1 USD -2.7% Market Closed
Market Cap: 5.4B USD
Have any thoughts about
Krystal Biotech Inc?
Write Note

Wall Street
Price Targets

KRYS Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast KRYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRYS is 219.1 USD with a low forecast of 196.95 USD and a high forecast of 257.25 USD.

Lowest
Price Target
196.95 USD
5% Upside
Average
Price Target
219.1 USD
17% Upside
Highest
Price Target
257.25 USD
37% Upside
Krystal Biotech Inc Competitors:
Price Targets
VITR
Vitrolife AB
65% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
88% Upside
ACLX
Arcellx Inc
68% Upside
BAVA
Bavarian Nordic A/S
79% Upside
4597
Solasia Pharma KK
45% Upside
2616
CStone Pharmaceuticals
25% Downside
002007
Hualan Biological Engineering Inc
32% Upside
TRDA
Entrada Therapeutics Inc
151% Upside

Revenue
Forecast

Revenue Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 43%.

N/A
Past Growth
43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's operating income for the next 3 years is 72%.

N/A
Past Growth
72%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 40%.

N/A
Past Growth
40%
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KRYS's stock price target?
Price Target
219.1 USD

According to Wall Street analysts, the average 1-year price target for KRYS is 219.1 USD with a low forecast of 196.95 USD and a high forecast of 257.25 USD.

What is Krystal Biotech Inc's Revenue forecast?
Projected CAGR
43%

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 43%.

What is Krystal Biotech Inc's Operating Income forecast?
Projected CAGR
72%

The compound annual growth rate of Krystal Biotech Inc's operating income for the next 3 years is 72%.

What is Krystal Biotech Inc's Net Income forecast?
Projected CAGR
40%

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 40%.

Back to Top